BTIG analyst Gray Powell downgrades Zscaler (NASDAQ:ZS) from Buy to Neutral.
Aligos Therapeutics Announced Friday A Research Collaboration And Development Agreement With Xiamen Amoytop Biotech Co. Ltd. For Use Of Aligos’ Oligonucleotide Platform For Treatment Of Liver Diseases
Aligos Therapeutics, Inc. (NASDAQ:ALGS, ", Aligos", , the ", Company", )))), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and
